Hong Kong-Listed Innovative Drug Stocks Surge at Session Opening, WuXi AppTec Jumps Over 3%
2025-07-31 / Read about 0 minute
Author:小编   

In the morning session, innovative drug-related stocks listed in Hong Kong exhibited robust performance. WuXi AppTec, Boan Biotechnology, and Eyebright Biotechnology all surged by more than 3%, while CSPC Pharmaceutical Group and Innovent Biologics also posted gains exceeding 2%. Recently, the National Healthcare Security Administration convened a symposium to deliberate on policy initiatives aimed at fostering the growth of innovative drugs and medical devices. Participants generally expressed optimism about the future trajectory of China's innovative drug and medical device industry.